Mangoceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mangoceuticals Inc's ROI in the second quarter of 2026?
Mangoceuticals Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -105.24%.

Within the Healthcare sector 351 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3481 to 4059.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-14.1 %	3.94 %	74.76 %	154.38 %	338.99 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	13	14	15	16	19
Return On Investment (TTM)	-105.24 %	-120.28 %	-117.27 %	-114.65 %	-85.01 %
MGRX's Overall Ranking	# 4059	# 3481	# 3591	# 3495	# 3253
Seq. Investment Change TTM	-10.12 %	-9.29 %	1.81 %	3.48 %	8.76 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-15	-19	-21	-20	-14

MGRX Company Profile >> Back to MGRX Roi Comparisons >> See Annual MGRX Return On Investment

Return On Investment MGRX's Ranking
Within:	No.
Industry	# 24
Sector	# 352
Overall	# 4059

Return On Investment Statistics
High	Average	Low
-72.42 %	-200.53 %	-720.35 %
(Mar 31 2025)		(Mar 31 2024)

Financial Statements
Mangoceuticals Inc's II. Quarter Investments	$ 13 Millions	MGRX's Balance sheet
Mangoceuticals Inc's II. Quarter Income	$ -1 Millions	Quarterly MGRX's Income Statement
MGRX's Income by Division		See MGRX's Income by Division

MGRX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023
Total Investments in Millions	15	14	1	0	0
Y / Y Investment Growth	8.99 %	1560.6 %	-	-	-
Net Income in Millions	-21	-9	-9	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-135.83 %	-62.44 %	-1097.12 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MGRX's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MGRX's Competitors
Subscribers only: Roi for Mangoceuticals Inc's Suppliers
Subscribers only: Return On Investment for MGRX's Customers

Other Ratios
MGRX's Roa	MGRX's Inventory Turnover Ratio	MGRX's Growth Rates	MGRX's Dividend Statistics
	MGRX's Profitability Ratios	MGRX's Asset Turnover Ratio	MGRX's Dividend Growth
MGRX's Roe	MGRX's Valuation Ratios	MGRX's Financial Strength Ratios	MGRX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-02T20:16:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.